In this episode of NETWise, we’re diving into one of the more aggressive forms of neuroendocrine cancer: neuroendocrine carcinoma (NEC). While many neuroendocrine tumors are slow-growing and manageable over time, NEC is different—fast-moving and requiring swift, specialized care.

• We’ll guide you through the essential information about NEC, including:
  What neuroendocrine carcinoma is and how it differs from other NETs
• The diagnostic process: what to expect and how doctors identify this disease
• Current treatment options and what patients and caregivers should know If you or a loved one has recently received an NEC diagnosis, this episode is designed to help you start understanding the road ahead.

Resourceshttps://www.thehealingnet.org/high-grade-neuroendocrine

High Grade Neuroendocrine Carcinoma Group

AcknowledgementsDr. Carl Gay, MD, PhD, is a thoracic medical oncologist and research scientist at the University of Texas MD Anderson Cancer Center.

Dr. Aman Chauhan, MD, is a medical oncologist at the Sylvester Comprehensive Cancer Center at the University of Miami, where he leads the neuroendocrine cancer program.

Dr. Renuka Iyer is a medical oncologist at Roswell Park Comprehensive Cancer Center in Buffalo, New York.

Susan Meckler Plummer, RN, runs an online support group for patients with neuroendocrine carcinoma.

Patient AcknowledgementsA special thank you to Deb Roberston and Lori Dolnick for sharing their stories. Click here to download a transcript of this episode.The post NETWise Episode 46: Understanding Neuroendocrine Carcinoma appeared first on NETRF.